EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study)

Alicia Santos, Marcelo Brito, Evellyn Silva, Felipe Rocha, Ana Oliveira, Rafaela Dávila, Hiran Gama, Jéssica Albuquerque, Mena Paiva, Djane Baía-Silva, Vanderson Sampaio, Patrícia Balieiro und 10 weitere

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Alicia Santos und 21 weiteren Autor:innen. Beteiligte Einrichtung: Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil. Hauptthemen laut MEDLINE: Malaria, Vivax, Antimalarials, Aminoquinolines, Glucosephosphate Dehydrogenase Deficiency. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development (CNPq), Ministry of Health of Brazil, Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effective radical cure of Plasmodium vivax malaria is essential for malaria elimination in Brazil. P . vivax radical cure requires administration of a schizonticide, such as chloroquine, plus an 8-aminoquinoline. However, 8-aminoquinolines cause hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, requiring prior screening to exclude those at risk. Brazil is pioneering the implementation of tafenoquine, a single-dose 8-aminoquinoline indicated for P . vivax patients with >70% of normal G6PD activity. Tafenoquine implementation in Manaus and Porto Velho, two municipalities located in the western Brazilian Amazon, included comprehensive training of healthcare professionals (HCPs) on point-of-care quantitative G6PD testing and a new treatment algorithm for P . vivax radical cure incorporating tafenoquine. Training was initially provided to higher-level facilities (phase one) and later adapted for primary care units (phase two). This study analyzed HCP experiences during training and implementation and identified barriers and facilitators. In-depth interviews and focus discussion groups were conducted 30 days after each training for a purposive random sample of 115 HCPs. Thematic analysis was employed using MAXQDA software, analyzing data through inductive and deductive coding. Analysis showed that following the initial training for higher-level facilities, some HCPs did not feel confident performing quantitative G6PD testing and prescribing the tafenoquine regimen. Modifications to the training in phase two resulted in an improvement in understanding the implementation process of the G6PD test and tafenoquine, as well as in the knowledge acquired by HCPs. Additionally, knowledge gaps were addressed through in situ training, peer communication via a messaging app, and educational materials. Training supported effective deployment of the new tools in Manaus and Porto Velho and increased awareness of the need for pharmacovigilance. A training approach for nationwide implementation of these tools was devised. Implementing quantitative G6PD testing and tafenoquine represents a significant shift in P . vivax malaria case management. Consistent engagement with HCPs is needed to overcome challenges in fully integrating these tools within the Brazilian health system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, VivaxAntimalarialsAminoquinolinesGlucosephosphate Dehydrogenase DeficiencyHealth PersonnelHumansBrazilFemaleGlucosephosphate DehydrogenaseMalePlasmodium vivaxAdult

Substanzen

tafenoquineAntimalarialsAminoquinolinesGlucosephosphate Dehydrogenase

Autor:innen und Institutionen

  • Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.
  • Universidade do Estado do Amazonas, Manaus, Brazil.
  • Centro de Pesquisa em Medicina Tropical de Rondônia (CEPEM), Porto Velho, Brazil.
  • Medicines for Malaria Venture, Geneva, Switzerland.
  • Brazilian Ministry of Health, Brasília, Brazil.
  • Fundação de Vigilância em Saúde, Manaus, Brazil.

ORCID-Profile: Felipe Murta

Förderung

  • National Council for Scientific and Technological Development (CNPq)
  • Ministry of Health of Brazil
  • Bill & Melinda Gates Foundation
  • Brazilian National Council for Scientific and Technological Development (CNPq)
  • National Council for Scientific and Technical Development
  • Ministry of Health Brazil
  • Bill and Melinda Gates Foundation
  • Medicines for Malaria Venture

Zitieren

APA

Santos, A., Brito, M., Silva, E., Rocha, F., Oliveira, A., Dávila, R., Gama, H., Albuquerque, J., Paiva, M., Baía-Silva, D., Sampaio, V., Balieiro, P., Rufatto, R., Grewal Daumerie, P., Peterka, C., Edilson Lima, F., Monteiro, W., Arcanjo, A., Silva, R., …, & Murta, F. (2024). Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study). PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012197

Vancouver

Santos A, Brito M, Silva E, Rocha F, Oliveira A, Dávila R, et al. Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study). PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012197

BibTeX
@article{Santos2024,
  author = {Santos, Alicia and Brito, Marcelo and Silva, Evellyn and Rocha, Felipe and Oliveira, Ana and Dávila, Rafaela and Gama, Hiran and Albuquerque, Jéssica and Paiva, Mena and Baía-Silva, Djane and Sampaio, Vanderson and Balieiro, Patrícia and Rufatto, Rosilene and Grewal Daumerie, Penny and Peterka, Cássio and Edilson Lima, Francisco and Monteiro, Wuelton and Arcanjo, Ana and Silva, Ricardo and Batista Pereira, Dhelio and Lacerda, Marcus and Murta, Felipe},
  title = {Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study)},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012197}
}
Kostenlos starten →